Pentoxyverine (NYAL DRY COUGH MEDICINE pentoxyverine citrate 1.5 mg/mL oral liquid bottle)
What to know about Pentoxyverine — also sold as NYAL DRY COUGH MEDICINE pentoxyverine citrate 1.5 mg/mL oral liquid bottle: uses, side effects, interactions, and safety considerations for people taking it or caring for someone who is.
Pentoxyverine (brand names: NYAL DRY COUGH MEDICINE pentoxyverine citrate 1.5 mg/mL oral liquid bottle) is classified as Low risk (2 risk points) by AllMeds. It is a S4 medication under the TGA in Australia. Antitussive with mild CNS depressant effects that may impair workplace performance.
Key Takeaways
- TGA Schedule: S4 in Australia
- Risk level: Low (2 points)
- CNS depressant: May cause sedation, impair driving, and affect work capacity
- Recommended maximum duration: 14 days
Scheduling and Classification
| Jurisdiction | Classification | Status |
|---|---|---|
| Australia (TGA) | S4 | Not PBS listed |
Risk Profile
Antitussive with mild CNS depressant effects that may impair workplace performance.
How Pentoxyverine is regulated
Pentoxyverine is overseen by medicines regulators in each country. The rules below explain how it's scheduled, what oversight applies, and what to discuss with your doctor or pharmacist before starting, changing, or stopping this medication.
Work capacity impact: As a CNS depressant, Pentoxyverine may impair driving, operating machinery, and cognitive function. Work capacity certificates should reflect any medication-related restrictions.
Australia TGA / PBS / State Schemes
Classified as S4 under the Therapeutic Goods Administration (TGA).
Check this medication against your full medication list
Run a full risk assessment including Pentoxyverine interactions and compliance checks.
Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile in minutes. Free for individuals; team plans for case managers, insurers, and schemes.
Important: This page is general health information, not personal medical advice. If you have questions about your medication — including starting it, stopping it, changing the dose, or combining it with something else — speak with your doctor or pharmacist. For an emergency or suspected overdose, call your local emergency number or poison information service immediately. Information is drawn from regulator and clinical guideline sources (TGA, FDA, MHRA, NICE, PBS, CDC); see our methodology for details.